July 18, 2023

Pub Committee Meeting July 2023 7-18-23

Meeting Minutes: QI Collaborative Publications Committee Meeting, July, 18, 2023

Co–Chairs: Dr. Shivani Agarwal and Dr. Shideh Majidi

Attendees: Shideh Majidi, Shivani Agarwal, Holly Hardison, Nicole Rioles, Margaret Zupa, Emly Breidbart, Ruth Weinstock, Liz Mann, Sean DeLacy, Manu Kamboj, Naomi Fogel, Carla Demeterco-Berggren, Saketh Rompicherla, Monica Bianco, Corrine Aia, Halis Kaan Akturk, Priya Prahalad, Siham Accacha, Ryan McDonough, Ori Odugbesan

Agenda

Publications updates
Upcoming Conferences
- November Learning Session
- ATTD 2024
- ADA 2024
ATTD 2023 Abstract Brainstorming

Publications updates

Upcoming Conferences

November Learning Session (November 14-15)
- Poster submission deadline: 7/31

ATTD 2024

Data request deadline 8/4

ADA 2024

Data request deadline 10/24

ATTD 2024 Abstract Brainstorming

Equity/SDOH topics are coming in (for LS- topics of interest)
Manu (Nationwide) suggested focusing on the four groups with group co-authors: 1) HCL, 2) Glucose monitoring, 3) Diabetes Distress, 4) Transitions of care (with multiple co-authors for each work group)
Different age groups
Carla/Rady Children’s- technology is changing at how providers are prescribing on devices. Predicting. Have HCL changed way you prescribed? Age of start? Honeymoon or post honeymoon? How comfortable are you to give advice on all HCL devices?
Ruth, SUNY Time to get in target after dx to get A1c down. Getting A1c down. Also measure change over time after CGM initiation.
Ruth- older adults: SUNY found that with significant training, very high percentage stays on CGM. Capturing glucometerics
Ryan/Children’s Mercy: Provider behavior is on the prescriptions. Time lapsed study. You can see relative uptick, compare over time with new devices. Takes a while to get on people’s formularies. Can go in by NPI. What is the pattern? How is different in new attendings vs long practicing attendings?
Adoption
Sihan, NYU Mineola- education. Who is educating? Internal cdces? External?
Liz/Wisconsin Trajectory in de-adoption. What are those options when they take devices off? How does data change? Start and stop. Sustaining use.
% time use. Prescriptions vs use. Does not correlate. Looking at barriers to use, Race, ethnicity, insurance plus reasons for barriers.
Some providers are uncomfortable with some devices. Seeing lots of gaps.
Liz, Wisconsin: look at time to target. Equity factors to start. Clinic level factors? Sustainability of use. Threshold of start and stop lessons learned
Naomi Fogel, Lurie Children’s- looking at barriers and reasons why CGM does not start or continue. Tracking in EMR: whether prescribed. Why and why not.
Emily, NYU Langone- do we send kids home with CGM who are newly dx? Look at family stress levels.
Margaret, UPMC- adverse events with device use. Do you bring them in with a site failure. Should we bring in annual to remind what to do during device failures
Use trainers- Shivani (Albert Einstein) to address failures. Siham relies on educators, not external trainers.
Look at CDE resource- who has/has not.
Liz- look at DKA events for time period during pumps. Many on Omnipod 5 went on DKA
Manu, Nationwide: DKA rates by pump/device type and outcomes and A1c results
Discussion of what happens with device failure. Is that information being properly reported? Is there annual education on what to do when devices fail to keep BG in safe range.
- Questions about what relevant questions are being asked in the annual survey- is this data available?
- To do: we will review questions and share them
- Group asked about qualitative surveys to ask about clinic processes/communications regarding devices failures with patients and families
- Brainstorming next steps: group is asked to read minutes and the different brainstorm ideas to potentially groups of 1, 2, 3, or 4 concepts together for a single abstract idea. Groups should then email T1DX, using form, to complete a data request for the abstract.